Feb. 29, 2024

The American College of Radiology® (ACR®) Committee on Drugs and Contrast Media this week released a revised contrast statement that provides flexibility to facilities for contrast studies while maintaining patient safety.

If a physician provides direct supervision for the study — on-site or remotely — the revised statement makes clear a medical professional trained to manage contrast reactions should be on-site.

Healthcare providers with the capabilities specified in the contrast statement can provide the service on-site, as long as those qualifications and the process are consistent with state and local laws and policies, as well as the process and policies of the service site.


Related ACR News

  • ACR Notice on Iodinated Contrast Media Access

    Contrast supply is mostly stable, but high demand causes variability; ACR urges ordering only what’s needed.

    Read more
  • ACR 2026: Evaluating AI Within Your Practice

    AI panel highlighted tools for evaluating and integrating AI, stressing data-driven decisions, governance, and AI’s impact on radiology workflows.

    Read more
  • ACR 2026 Economics Forum Talks Efficiency, AI, Fair Payment

    The forum covered CMS efficiency cuts, NSA dispute surge, policy impacts, and new AI economics efforts in radiology reimbursement.

    Read more